CONSOLIDATED STATEMENTS OF INCOME - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues	$ 24,120,434	$ 34,666,653
Cost of revenues	14,817,028	15,425,178
Gross profit	9,303,406	19,241,475
Operating expenses
Selling, general and administrative	15,091,432	11,656,681
Impairment of intangible asset	382,414	0
Loss on abandonment of assets	42,898	0
Depreciation and amortization	2,124,762	1,483,140
Total operating expenses	17,641,506	13,139,821
Income (loss) from operations	(8,338,100)	6,101,654
Other income
Interest income	90,720	441,116
Income (loss) before income tax provision (benefit) and noncontrolling interest	(8,247,380)	6,542,770
Income tax provision (benefit)	894,182	(909,976)
Net income (loss) before noncontrolling interest	(9,141,562)	7,452,746
Net loss attributable to noncontrolling interest	0	1,573
Net income (loss) attributable to Paysign, Inc.	$ (9,141,562)	$ 7,454,319
Net income (loss) per share
Basic	$ (0.19)	$ 0.16
Diluted	$ (0.19)	$ 0.14
Weighted average common shares
Basic	49,272,494	47,436,754
Diluted	49,272,494	54,550,369
Plasma Industry [Member]
Revenues	$ 23,401,068	$ 26,994,929
Pharma industry [Member]
Revenues	326,699	7,372,990
Other [Member]
Revenues	$ 392,667	$ 298,734